Category

Cohort News

PanTher Therapeutics Initiates Phase 1b clinical trial of absorbable, long-lasting, high-dose chemotherapy patch for pancreatic cancer

//
Categories
AUSTIN, Texas–(BUSINESS WIRE)–PanTher Therapeutics (“PanTher” or the “Company”), a clinical-stage company redefining cancer treatment with therapeutics administered continuously and exclusively at the tumor site, today announced that the first patient has been treated with PTM-101 in a Phase 1b clinical...
Read More →